{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:34:03Z","timestamp":1772555643342,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2189-z","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T12:26:27Z","timestamp":1484396787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line"],"prefix":"10.1186","volume":"17","author":[{"given":"Dipanwita","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelakshi","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananya","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debraj","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manikankana","family":"Bandopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrima","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivaram Prasad","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sekhar","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runu","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,14]]},"reference":[{"key":"2189_CR1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.med.57.121304.131422","volume":"57","author":"ME Mailliard","year":"2006","unstructured":"Mailliard ME, Gollan JL. Emerging therapeutics for chronic hepatitis B. Annu Rev Med. 2006;57:155\u201366.","journal-title":"Annu Rev Med"},{"issue":"Pt 6","key":"2189_CR2","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1099\/vir.0.81920-0","volume":"87","author":"A Bertoletti","year":"2006","unstructured":"Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol. 2006;87(Pt 6):1439\u201349.","journal-title":"J Gen Virol"},{"issue":"15","key":"2189_CR3","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","volume":"79","author":"SF Wieland","year":"2005","unstructured":"Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol. 2005;79(15):9369\u201380.","journal-title":"J Virol"},{"issue":"1","key":"2189_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.23230","volume":"51","author":"J Lucifora","year":"2010","unstructured":"Lucifora J, Durantel D, Testoni B, Hantz O, Levrero M, Zoulim F. Control of hepatitis B virus replication by innate response of HepaRG cells. Hepatology. 2010;51(1):63\u201372.","journal-title":"Hepatology"},{"issue":"7","key":"2189_CR5","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1053\/j.gastro.2011.02.057","volume":"140","author":"M Lutgehetmann","year":"2011","unstructured":"Lutgehetmann M, Bornscheuer T, Volz T, Allweiss L, Bockmann JH, Pollok JM, Lohse AW, Petersen J, Dandri M. Hepatitis B virus limits response of human hepatocytes to interferon-alpha in chimeric mice. Gastroenterology. 2011;140(7):2074\u201383. 2083 e2071-2072.","journal-title":"Gastroenterology"},{"issue":"7","key":"2189_CR6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/17460441.2012.689281","volume":"7","author":"X Zhang","year":"2012","unstructured":"Zhang X, Kraft A, Broering R, Schlaak JF, Dittmer U, Lu M. Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections. Expert Opin Drug Discovery. 2012;7(7):597\u2013611.","journal-title":"Expert Opin Drug Discovery"},{"issue":"11","key":"2189_CR7","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","volume":"79","author":"M Isogawa","year":"2005","unstructured":"Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol. 2005;79(11):7269\u201372.","journal-title":"J Virol"},{"issue":"3","key":"2189_CR8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2012.05.004","volume":"57","author":"X Zhang","year":"2012","unstructured":"Zhang X, Ma Z, Liu H, Liu J, Meng Z, Broering R, Yang D, Schlaak JF, Roggendorf M, Lu M. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection. J Hepatol. 2012;57(3):522\u20138.","journal-title":"J Hepatol"},{"issue":"10","key":"2189_CR9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/jvh.12390","volume":"22","author":"N Sarkar","year":"2015","unstructured":"Sarkar N, Panigrahi R, Pal A, Biswas A, Singh SP, Kar SK, Bandopadhyay M, Das D, Saha D, Kanda T, et al. Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C\/EBP-beta in hepatocytes. J Viral Hepat. 2015;22(10):817\u201327.","journal-title":"J Viral Hepat"},{"issue":"9","key":"2189_CR10","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JVI.02066-09","volume":"84","author":"SY Kwon","year":"2010","unstructured":"Kwon SY, Park YK, Ahn SH, Cho ES, Choe WH, Lee CH, Kim BK, Ko SY, Choi HS, Park ES, et al. Identification and characterization of clevudine-resistant mutants of hepatitis B virus isolated from chronic hepatitis B patients. J Virol. 2010;84(9):4494\u2013503.","journal-title":"J Virol"},{"issue":"3","key":"2189_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000098960","volume":"50","author":"PK Chandra","year":"2007","unstructured":"Chandra PK, Banerjee A, Datta S, Chakravarty R. G1862T mutation among hepatitis B virus-infected individuals: association with viral genotypes and disease outcome in Kolkata, Eastern India. Intervirology. 2007;50(3):173\u201380.","journal-title":"Intervirology"},{"issue":"26","key":"2189_CR12","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1182\/blood-2010-04-280156","volume":"116","author":"H Zhou","year":"2010","unstructured":"Zhou H, Huang X, Cui H, Luo X, Tang Y, Chen S, Wu L, Shen N. miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood. 2010;116(26):5885\u201394.","journal-title":"Blood"},{"issue":"4","key":"2189_CR13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/MMBR.00025-06","volume":"70","author":"MA Bogoyevitch","year":"2006","unstructured":"Bogoyevitch MA, Kobe B. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev. 2006;70(4):1061\u201395.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"5","key":"2189_CR14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1053\/gast.1996.v110.pm8613059","volume":"110","author":"A Ozer","year":"1996","unstructured":"Ozer A, Khaoustov VI, Mearns M, Lewis DE, Genta RM, Darlington GJ, Yoffe B. Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication. Gastroenterology. 1996;110(5):1519\u201328.","journal-title":"Gastroenterology"},{"issue":"3","key":"2189_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-5793(01)02114-7","volume":"490","author":"J Bartek","year":"2001","unstructured":"Bartek J, Lukas J. Pathways governing G1\/S transition and their response to DNA damage. FEBS Lett. 2001;490(3):117\u201322.","journal-title":"FEBS Lett"},{"key":"2189_CR16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1743-422X-8-231","volume":"8","author":"T Wang","year":"2011","unstructured":"Wang T, Zhao R, Wu Y, Kong D, Zhang L, Wu D, Li C, Zhang C, Yu Z, Jin X. Hepatitis B virus induces G1 phase arrest by regulating cell cycle genes in HepG2.2.15 cells. Virol J. 2011;8:231.","journal-title":"Virol J"},{"issue":"1","key":"2189_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh186","volume":"17","author":"K Takeda","year":"2005","unstructured":"Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17(1):1\u201314.","journal-title":"Int Immunol"},{"issue":"4","key":"2189_CR18","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.22751","volume":"49","author":"J Wu","year":"2009","unstructured":"Wu J, Meng Z, Jiang M, Pei R, Trippler M, Broering R, Bucchi A, Sowa JP, Dittmer U, Yang D, et al. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology. 2009;49(4):1132\u201340.","journal-title":"Hepatology"},{"issue":"1","key":"2189_CR19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/hep.21482","volume":"45","author":"K Visvanathan","year":"2007","unstructured":"Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, Rodgers S, Kurtovic J, Chang J, Lewin S, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology. 2007;45(1):102\u201310.","journal-title":"Hepatology"},{"issue":"6","key":"2189_CR20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/v2061279","volume":"2","author":"E Clercq De","year":"2010","unstructured":"De Clercq E, Ferir G, Kaptein S, Neyts J. Antiviral treatment of chronic hepatitis B virus (HBV) infections. Viruses. 2010;2(6):1279\u2013305.","journal-title":"Viruses"},{"issue":"16","key":"2189_CR21","first-page":"1004","volume":"81","author":"H Cao","year":"2001","unstructured":"Cao H, Tao P. Anti-hepatitis B virus effects of lamivudine and other five drugs in vitro. Zhonghua Yi Xue Za Zhi. 2001;81(16):1004\u20137.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2189_CR22","doi-asserted-by":"crossref","unstructured":"Lanford RE, Guerra B, Chavez D, Giavedoni L, Hodara VL, Brasky KM, Fosdick A, Frey CR, Zheng J, Wolfgang G et al.: GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees. Gastroenterology 2013, 144(7):1508\u20131517, 1517 e1501-1510.","DOI":"10.1053\/j.gastro.2013.02.003"},{"issue":"2","key":"2189_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ceb.2007.02.001","volume":"19","author":"CR Weston","year":"2007","unstructured":"Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Cell Biol. 2007;19(2):142\u20139.","journal-title":"Curr Opin Cell Biol"},{"key":"2189_CR24","doi-asserted-by":"crossref","first-page":"367694","DOI":"10.1155\/2010\/367694","volume":"2010","author":"S Maeda","year":"2010","unstructured":"Maeda S. NF-kappaB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis. Gastroenterol Res Pract. 2010;2010:367694.","journal-title":"Gastroenterol Res Pract"},{"issue":"4","key":"2189_CR25","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1128\/JVI.71.4.3236-3243.1997","volume":"71","author":"VJ Cavanaugh","year":"1997","unstructured":"Cavanaugh VJ, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol. 1997;71(4):3236\u201343.","journal-title":"J Virol"},{"issue":"21","key":"2189_CR26","doi-asserted-by":"crossref","first-page":"10702","DOI":"10.1128\/JVI.76.21.10702-10707.2002","volume":"76","author":"K Kimura","year":"2002","unstructured":"Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol. 2002;76(21):10702\u20137.","journal-title":"J Virol"},{"issue":"9","key":"2189_CR27","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/JVI.74.9.4165-4173.2000","volume":"74","author":"SF Wieland","year":"2000","unstructured":"Wieland SF, Guidotti LG, Chisari FV. Intrahepatic induction of alpha\/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J Virol. 2000;74(9):4165\u201373.","journal-title":"J Virol"},{"issue":"11","key":"2189_CR28","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1128\/JVI.76.11.5646-5653.2002","volume":"76","author":"V Pasquetto","year":"2002","unstructured":"Pasquetto V, Wieland SF, Uprichard SL, Tripodi M, Chisari FV. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J Virol. 2002;76(11):5646\u201353.","journal-title":"J Virol"},{"issue":"9","key":"2189_CR29","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.4049\/jimmunol.171.9.4708","volume":"171","author":"SJ Lin","year":"2003","unstructured":"Lin SJ, Shu PY, Chang C, Ng AK, Hu CP. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B. J Immunol. 2003;171(9):4708\u201316.","journal-title":"J Immunol"},{"key":"2189_CR30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1146\/annurev.bi.46.070177.004435","volume":"46","author":"RD Kornberg","year":"1977","unstructured":"Kornberg RD. Structure of chromatin. Annu Rev Biochem. 1977;46:931\u201354.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"2189_CR31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jmb.2011.01.040","volume":"409","author":"KE Gardner","year":"2011","unstructured":"Gardner KE, Allis CD, Strahl BD. Operating on chromatin, a colorful language where context matters. J Mol Biol. 2011;409(1):36\u201346.","journal-title":"J Mol Biol"},{"issue":"1","key":"2189_CR32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/carcin\/bgt317","volume":"35","author":"Y Tian","year":"2014","unstructured":"Tian Y, Ni D, Yang W, Zhang Y, Zhao K, Song J, Mao Q, Tian Z, van Velkinburgh JC, Yang D, et al. Telbivudine treatment corrects HBV-induced epigenetic alterations in liver cells of patients with chronic hepatitis B. Carcinogenesis. 2014;35(1):53\u201361.","journal-title":"Carcinogenesis"},{"issue":"34","key":"2189_CR33","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1038\/sj.onc.1202867","volume":"18","author":"H Sirma","year":"1999","unstructured":"Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene. 1999;18(34):4848\u201359.","journal-title":"Oncogene"},{"issue":"5","key":"2189_CR34","first-page":"446","volume":"39","author":"P Shahnazari","year":"2014","unstructured":"Shahnazari P, Sayehmiri K, Minuchehr Z, Parhizkar A, Poustchi H, Montazeri G, Mohamadkhani A. The Increased Level of Serum p53 in Hepatitis B-Associated Liver Cirrhosis. Iran J Med Sci. 2014;39(5):446\u201351.","journal-title":"Iran J Med Sci"},{"issue":"8","key":"2189_CR35","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1128\/JVI.62.8.2836-2844.1988","volume":"62","author":"MA Sells","year":"1988","unstructured":"Sells MA, Zelent AZ, Shvartsman M, Acs G. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol. 1988;62(8):2836\u201344.","journal-title":"J Virol"},{"key":"2189_CR36","doi-asserted-by":"crossref","unstructured":"Su J, Jiang L, Wu J, Wu Y, Liu Z: Anti-tumor and anti-virus activity of polysaccharides extracted from Sipunculus nudus(SNP) on Hepg2.2.15. Int J Biol Macromol 2016.","DOI":"10.1016\/j.ijbiomac.2016.03.022"},{"key":"2189_CR37","doi-asserted-by":"crossref","unstructured":"Li B, Guo QL, Tian Y, Liu SJ, Wang Q, Chen L, Dong JX: New Anti-HBV C-Boivinopyranosyl Flavones from Alternanthera philoxeroides. Molecules 2016, 21(3).","DOI":"10.3390\/molecules21030336"},{"issue":"4","key":"2189_CR38","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/jmv.24366","volume":"88","author":"Z Cheng","year":"2016","unstructured":"Cheng Z, Zhi X, Sun G, Guo W, Huang Y, Sun W, Tian X, Zhao F, Hu K. Sodium selenite suppresses hepatitis B virus transcription and replication in human hepatoma cell lines. J Med Virol. 2016;88(4):653\u201363.","journal-title":"J Med Virol"},{"issue":"4","key":"2189_CR39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12250-015-3584-5","volume":"30","author":"Z Cheng","year":"2015","unstructured":"Cheng Z, Sun G, Guo W, Huang Y, Sun W, Zhao F, Hu K. Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines. Virol Sin. 2015;30(4):261\u20138.","journal-title":"Virol Sin"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2189-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T01:02:23Z","timestamp":1601341343000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2189-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,14]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2189"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2189-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,14]]},"article-number":"76"}}